GlassScriptPhysician profile
Andrew Kerner
NPI 1073002564
$891.14
in general payments reported to CMS, 2019-2025
9 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $351 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $229.17 | 2024 | Signia |
| Integra Lifesciences Corporation | $164.22 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cumberland Pharmaceuticals, INC. | $140.99 | 2024-2025 | Caldolor |
| Thd America, INC. | $106.07 | 2025 | |
| Boston Scientific Corporation | $97.42 | 2025 | General - Hemostasis |
| Rti Surgical, INC | $60.19 | 2025 | |
| Depuy Synthes Sales INC. | $58.47 | 2025 | Matrixmandible |
| Inspire Medical Systems, INC. | $19.61 | 2025 | Inspire |
| Ethicon US, LLC | $15.00 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.